The results showed that compared with other preparations, MPDA@SPIO/SA-PEI/AFP-Fth had better ability to enhance MRI contrast of T2-weighted images in tumor region, and could be used as an effective MRI contrast agent for early detection of hepatocellular carcinoma (HCC). This evidence concerns the gene AFP and hepatocellular carcinoma.